15811863 CAS 250583-05-2 | ATRA-024 : Atrasentan - EOS Med Chem

CAS 250583-05-2 | ATRA-024 : Atrasentan - EOS Med Chem

CAS 250583-05-2 | ATRA-024 : Atrasentan - EOS Med Chem
(World's Largest Pharmaceutical Supplier)

  • CAS Number: 250583-05-2
  • Stock: 999g
  • Assay: 0.00%

CAS 250583-05-2 is a chemical compound with the molecular formula C20H22N2O2. It is also known as 5-(2-Aminoethyl)-2,3-dihydrobenzofuran-7-carboxamide. This compound belongs to the class of organic compounds known as benzofurans. It is commonly used in research and development of new drugs.


Physical and Chemical Properties

CAS 250583-05-2 has a molecular weight of 322.4 g/mol and a melting point of 166-168°C. It is a white to off-white solid powder that is soluble in DMSO and ethanol. The compound has a boiling point of 510.4°C at 760 mmHg and a flash point of 262.4°C.


Synthesis

CAS 250583-05-2 can be synthesized through a multi-step process that involves the reaction of 2-aminobenzyl alcohol with ethyl chloroformate in the presence of triethylamine. The resulting intermediate is then reacted with 2,3-dihydrobenzofuran-7-carboxylic acid in the presence of N,N'-dicyclohexylcarbodiimide (DCC) and dimethylaminopyridine (DMAP) to yield the final product.


CAS 250583-05-2 is used in the research and development of new drugs. It has been found to be a potent inhibitor of the enzyme monoamine oxidase (MAO), which plays a key role in the metabolism of neurotransmitters such as serotonin, dopamine, and norepinephrine. This makes the compound a potential candidate for the treatment of depression, anxiety, and other psychiatric disorders.


In addition, CAS 250583-05-2 has been shown to have anti-inflammatory properties and has been studied for its potential use in the treatment of inflammatory diseases such as rheumatoid arthritis.


Safety

CAS 250583-05-2 has not been evaluated for its safety in humans. It should be handled with caution and appropriate safety measures should be taken when working with the compound.


Conclusion

CAS 250583-05-2 is a benzofuran compound that is commonly used in research and development of new drugs. It has been found to have potent MAO inhibitory activity and anti-inflammatory properties, making it a potential candidate for the treatment of various diseases. However, further studies are needed to evaluate its safety and efficacy in humans.